| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 4V7M9137X9 |
| InChI Key | YKGYIDJEEQRWQH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H23N3O4 |
| Molecular Weight | 321.38 |
| AlogP | 1.6 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 117.0 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | 27000 | - | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 1350 | - | 1900 | - | |
|
Enzyme
Protease
Serine protease
|
- | 1350 | - | 1900 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 900 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | 10800 | - | - | 96 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Liver Diseases | 3 | D008107 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 93036 |
| ChEMBL | CHEMBL87563 |
| DrugBank | DB12831 |
| DrugCentral | 3257 |
| EPA CompTox | DTXSID9048566 |
| FDA SRS | 4V7M9137X9 |
| Guide to Pharmacology | 7863 |
| PubChem | 3447 |
| SureChEMBL | SCHEMBL446024 |
| ZINC | ZINC000002002226 |